AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Phase II clinical data reported for 7-day patch.
2003 MAR 6 - (NewsRx.com & NewsRx.net) -- Agile Therapeutics, Inc., announced that an analysis of data from the Phase II clinical trial of its seven-day translucent contraceptive patch indicates that ovulation was suppressed by more than 95% throughout the three-month study.
The trial evaluated 225 menstrual cycles in which a transdermal system was applied for each of the first three weeks of each cycle followed by a week without any patch.
Importantly, results from this trial show lower than expected hormone-induced side effects and demonstrate an overall tolerability and safety profile consistent with expectations.
"Based on these results, Agile Therapeutics has begun to transfer the manufacturing of the patch to a large-scale GMP manufacturer. We are pleased with the results to date. The suppression of ovulation coupled with the low incidence of breast tenderness, nausea, vomiting, and weight gain are very promising. Moreover, subjects were comfortable with the patch," said Tom Stagnaro, Agile ...
- Agile Therapeutics Reports Positive Phase 2 Clinical Data For 7-Day...
- Press release article from: PR Newswire February 6, 2003 700+ words
...PRNewswire/ -- Agile Therapeutics, Inc. announced...these results, Agile Therapeutics has begun to transfer...the patch," said Tom Stagnaro, President and...Executive Officer. Agile Therapeutics has begun discussions...
- Agile Therapeutics Engages Legg Mason.
- Press release article from: PR Newswire May 1, 2003 700+ words
...chosen to assist Agile Therapeutics in this important...trol-7 TM." Agile Therapeutics (agiletherapeutics...develops. (Contact: Tom Stagnaro at 610 940-0300...President and CEO of Agile Therapeutics, +1-610-940...
- Agile Therapeutics Initiates Clinical Trial of 7-Day Combination Contraceptive...
- Press release article from: PR Newswire July 10, 2002 700+ words
...Australia. The Agile Therapeutics patch will...regimens," said Tom Stagnaro, President...patch." Agile Therapeutics (http...Contact: Tom Stagnaro at 610 940...0950, for Agile Therapeutics; or Business...
- Agile Therapeutics Initiates Two Clinical Trials on 7-Day Combination...
- Press release article from: PR Newswire May 17, 2001 700+ words
...PRNewswire/ -- Agile Therapeutics, Inc. (formerly...about 12 months. The Agile Therapeutics patch will compete...regimens," said Tom Stagnaro, President and Chief...develops. (Contact: Tom Stagnaro at 610-940-0300...
- Daria Blackwell Joins Agile Therapeutics Board of Directors.
- Magazine article from: Women's Health Weekly January 24, 2002 700+ words
...NewsRx.net) -- Agile Therapeutics, Inc., has appointed...Communications. "The entire Agile Therapeutics Board recognizes...Communications Council. Agile Therapeutics is a development...develops. (Contact: Tom Stagnaro at 610-940-0300...
- Agile Therapeutics Initiates New Clinical Trials On 7-Day Combination...
- Press release article from: PR Newswire August 7, 2001 700+ words
...Aug. 7 /PRNewswire/ -- Agile Therapeutics, Inc. (formerly Levotech...trials have commenced," said Tom Stagnaro, President and CEO. "Agile...than rectangular patches. Agile Therapeutics is a transdermal delivery...
- Agile Therapeutics Closes $12 Million Financing for Development of a Low...
- Press release article from: PR Newswire May 25, 2006 700+ words
...Pa., May 25 /PRNewswire/ -- Agile Therapeutics has completed a $12 million equity...ProQuest Investments, a new investor to Agile Therapeutics. All investors from earlier rounds...said Dr. Thomas M. Rossi, CEO of Agile Therapeutics. "I'm very gratified that the...
- Lisa Flood Joins Agile Therapeutics.
- Press release article from: PR Newswire June 27, 2007 700+ words
...Lisa Flood, BSN, has joined Agile Therapeutics Inc as Associate Director of Regulatory...submissions, and clinical operations. Agile Therapeutics is an emerging bio-pharmaceutical...pleased to have Lisa joining the Agile Therapeutics development team," said CEO Thomas...